glp 1 agonist 종류 학술특집] 최근 당뇨치료의 세계적 이슈, '인크레틴 제제'1 < 학술연구 < 학술·학회 < 기사본문 Glucagon-Like Peptide 1 수용체작용제 최신지견
Description
What remains clear is that the obesity therapeutics market, already among the fastest-growing segments in pharmaceutical history, is entering a dramatically larger phase of expansion
10.1016/j.coph.2023.102355 [DOI] [PubMed] [Google Scholar] 7
![glp 1 agonist ] , ' '1 < < < Glucagon-Like Peptide 1](http://webzine.koita.or.kr/storage/app/public/media/public/media_library/f7/cf/20200826104639efa88c925fbb79f6f7e39cb088e9ee0aa342fafd.jpg)
doi: 10.1016/j.drudis.2015.07.015
![glp 1 agonist ] , ' '1 < < < Glucagon-Like Peptide 1](https://fbi-reports-file.s3.us-west-2.amazonaws.com/fbi_l/infographics-svg-webp/glp-1_receptor_agonist_market.webp)
Contamination or degradation affects not one pathway but three